Search Results - "Kamdar, M."

Calciphylaxis: Risk Factors, Diagnosis, and Treatment by Nigwekar, Sagar U., MD, MMSc, Kroshinsky, Daniela, MD, MPH, Nazarian, Rosalynn M., MD, Goverman, Jeremy, MD, Malhotra, Rajeev, MD, Jackson, Vicki Ann, MD, MPH, Kamdar, Mihir M., MD, Steele, David J.R., MD, Thadhani, Ravi I., MD, MPH

“…Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions in the scientific…”
Get full text

An Overview of Significant Achievements in Ruthenium-Based Molecular Water Oxidation Catalysis by Kamdar, Jayneil M, Grotjahn, Douglas B

“…Fossil fuels (coal, oil, natural gas) are becoming increasingly disfavored as long-term energy options due to concerns of scarcity and environmental…”
Get full text

Mapping the Milky Way in 5D with 170 Million Stars by Speagle, Joshua S., Zucker, Catherine, Bonaca, Ana, Cargile, Phillip A., Johnson, Benjamin D., Beane, Angus, Conroy, Charlie, Finkbeiner, Douglas P., Green, Gregory M., Kamdar, Harshil M., Naidu, Rohan, Rix, Hans-Walter, Schlafly, Edward F., Dotter, Aaron, Eadie, Gwendolyn, Eisenstein, Daniel J., Goodman, Alyssa A., Han, Jiwon Jesse, Saydjari, Andrew K., Ting, Yuan-Sen, Zelko, Ioana A.

“…Abstract We present Augustus , a catalog of distance, extinction, and stellar parameter estimates for 170 million stars from 14 mag < r < 20 mag and with ∣ b ∣…”
Get full text

Increasing Ligand Denticity and Stability for a Water Oxidation Electrocatalyst using P(V) as Connecting Element by Saeedifard, Farzaneh, Breyer, Colton J., Chi Cao, Thomas, Kamdar, Jayneil M., Kerkhof, Jake, Smith, Diane K., Cooksy, Andrew L., Rheingold, Arnold L., Moore, Curtis E., Gu, Jing, Grotjahn, Douglas B.

“…Carboxylate complexes have risen to prominence in the field of water oxidation catalysis. Here for the first time we use the higher valence of phosphinates…”
Get full text

Top 10 Things Palliative Care Clinicians Wished Everyone Knew About Palliative Care by Strand, Jacob J., MD, Kamdar, Mihir M., MD, Carey, Elise C., MD

“…Abstract With a focus on improving quality of life for patients, palliative care is a rapidly growing medical subspecialty focusing on the care of patients…”
Get full text

Adult cancer pain by Swarm, Robert A, Abernethy, Amy Pickar, Anghelescu, Doralina L, Benedetti, Costantino, Buga, Sorin, Cleeland, Charles, Deleon-Casasola, Oscar A, Eilers, June G, Ferrell, Betty, Green, Mark, Janjan, Nora A, Kamdar, Mihir M, Levy, Michael H, Lynch, Maureen, McDowell, Rachel M, Moryl, Natalie, Nesbit, Suzanne A, Paice, Judith A, Rabow, Michael W, Syrjala, Karen L, Urba, Susan G, Weinstein, Sharon M, Dwyer, Mary, Kumar, Rashmi

“…Pain is a common symptom associated with cancer and its treatment. Pain management is an important aspect of oncologic care, and unrelieved pain significantly…”
Get more information

CLINICAL AND RADIOGRAPHIC FACTORS PRIOR TO CAR T‐CELL THERAPY ACCURATELY IDENTIFY RELAPSED/REFRACTORY LYMPHOMA PATIENTS AT HIGH RISK FOR PROGRESSION AND POOR SURVIVAL by Jodon, G., Colton, M. D., Cai, A. R., Haverkos, B., Morgan, R., Kamdar, M.

Get full text

How Do Proximal Hydroxy or Methoxy Groups on the Bidentate Ligand Affect [(2,2′;6′,2"-Terpyridine)Ru(N,N)X] Water-Oxidation Catalysts? Synthesis, Characterization, and Reactivity at Acidic and Near-Neutral pH by Marelius, David C., Bhagan, Salome, Charboneau, David J., Schroeder, Kristine M., Kamdar, Jayneil M., McGettigan, Amanda R., Freeman, Benjamin J., Moore, Curtis E., Rheingold, Arnold L., Cooksy, Andrew L., Smith, Diane K., Paul, Jared J., Papish, Elizabeth T., Grotjahn, Douglas B.

“…Water‐oxidation catalysts (WOCs) can potentially be improved by installing pendant electron‐donor groups that may also be proton donors or acceptors. We have…”
Get full text

Comparison of overall survival of lisocabtagene maraleucel (liso‐cel) versus standard of care (SOC) adjusting for crossover in second‐line (2L) R/R large B‐cell lymphoma by Morschhauser, F., Ghesquieres, H., Kamdar, M., Liu, F. F., Chandler, C., Crotta, A., Klijn, S. L., Elsada, A., Previtali, A., Chaillol, I., Proskorovsky, I., Schmitz, N., Gisselbrecht, C., Abramson, J. S.

Get full text

A CASE SERIES OF PATIENTS WITH CUTANEOUS T‐CELL LYMPHOMA TREATED WITH COMBINATION MOGAMULIZUMAB AND OTHER THERAPIES AFTER SINGLE AGENT MOGAMULIZUMAB by Treitman, R., Colton, M. D., Srivastava, P., Tobin, J., Marciano, K., Rezac, R., Major, A., Kamdar, M., Bair, S., Jasem, J., Pacheco, T., Haverkos, B.

Get full text

Plain language summary of the TRANSFORM study primary analysis results: liso-cell as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen by Abramson, Jeremy S, Solomon, Scott R, Arnason, Jon, Johnston, Patrick B, Glass, Bertram, Bachanova, Veronika, Ibrahimi, Sami, Mielke, Stephan, Mutsaers, Pim, Hernandez-Ilizaliturri, Francisco, Izutsu, Koji, Morschhauser, Franck, Lunning, Matthew, Crotta, Alessandro, Montheard, Sandrine, Previtali, Alessandro, Ogasawara, Ken, Kamdar, Manali

Get more information

LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN R/R MCL: PRIMARY ANALYSIS RESULTS FROM THE MCL COHORT OF THE SINGLE‐ARM, MULTICENTER, SEAMLESS DESIGN TRANSCEND NHL 001 STUDY by Wang, M., Siddiqi, T., Gordon, L. I., Kamdar, M., Lunning, M., Hirayama, A. V., Abramson, J. S., Arnason, J., Ghosh, N., Mehta, A., Andreadis, C., Solomon, S. R., Kostic, A., Dehner, C., Espinola, R., Peng, L., Ogasawara, K., Chattin, A., Palomba, M. L.

Get full text

LISOCABTAGENE MARALEUCEL (LISO‐CEL) VERSUS STANDARD OF CARE (SOC) AS SECOND‐LINE THERAPY IN LARGE B‐CELL LYMPHOMA (TRANSFORM STUDY): SUBGROUP ANALYSES BY PRIOR THERAPY RESPONSE by Nastoupil, L. J., Kamdar, M., Chavez, J. C., Ghesquieres, H., Ghosh, M., Holmes, H., López‐Guillermo, A., Martínez‐López, J., Novak, U., Ribrag, V., Roddie, C., Waller, E. K., Feldman, T., Rosenthal, A. C., Sauter, C., Bonin, M., Karmali, R., Montheard, S., Previtali, A., Abramson, J.

Get full text

OUTCOMES OF AUTOLOGOUS TRANSPLANT, ALLOGENEIC TRANSPLANT, AND CAR T CELL THERAPY IN TP53 ALTERED MANTLE CELL LYMPHOMA: A MULTI‐INSTITUTION RETROSPECTIVE ANALYSIS by Messmer, M., Stack, A., Deng, M., Handorf, E., Kapoor, N., Sawalha, Y., Bock, A. M., Wang, Y., Graf, K., Greenwell, B., Cleveland, J., Advani, R., Herrera, D. Adrianzen, Cai, E., Spinner, M., Hassan, A., Rajguru, S., Phillips, M. S., Smith, S. D., Brooks, T., Bond, D., Hill, B., Murphy, J., Wagner‐Johnston, N., Zahid, M., Awan, F. T., Geethakumari, P. Ramakrishnan, Tompkins, W., Deshpande, S., Svoboda, J., Ryu, C., Amengual, J., Anna, J., Kamdar, M., Goparaju, K., Martin, J., Burkart, M., Karmali, R., Khan, A., Modi, D., Nickel, M., Hambley, B., Baron, K., Shah, H., Wallace, D., Friedberg, J. W., Hannah, C., Bachanova, V., Ghosh, N., Park, S., David, K., Darrah, J., Fisher, R. I., Khan, N.

Get full text

A Novel Modified Retrocrural Approach for Celiac Plexus Block: The Single-Needle Retroaortic Technique by Kamdar, Mihir M, Edwards, David A, Thabet, Ashraf M, Volney, Shane J, Rathmell, James P

“…ABSTRACTFor patients with pain from upper abdominal malignancies, celiac plexus neurolysis can provide an effective means of pain control. However, there are…”
Get full text

Opioid Use After Knee Arthroscopy by Kamdar, Parth M., Mandava, Nikhil K., Narula, Aastha, Patel, Pushpendra P., Vadasdi, Katherine B., Greene, R. Timothy, Alberta, Frank G., Sethi, Paul M.

“…To quantify the use of 5 mg oxycodone by patients who have undergone knee arthroscopy. Patients who underwent knee arthroscopy at 2 institutions between May…”
Get full text

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR FOLLOW‐UP OF ELEVATE‐TN by Sharman, J. P., Egyed, M., Jurczak, W., Skarbnik, A., Patel, K., Flinn, I. W., Kamdar, M., Munir, T., Walewska, R., Fogliatto, L. M., Herishanu, Y., Banerji, V., Follows, G., Walker, P., Karlsson, K., Ghia, P., Janssens, A., Cymbalista, F., Ferrant, E., Wierda, W. G., Munugalavadla, V., Yu, T., Wang, M. H., Woyach, J. A.

Get full text

Machine learning and cosmological simulations – II. Hydrodynamical simulations by Kamdar, Harshil M, Turk, Matthew J, Brunner, Robert J

“…We extend a machine learning (ML) framework presented previously to model galaxy formation and evolution in a hierarchical universe using N-body +…”
Get full text

Machine learning and cosmological simulations – I. Semi-analytical models by Kamdar, Harshil M, Turk, Matthew J, Brunner, Robert J

“…We present a new exploratory framework to model galaxy formation and evolution in a hierarchical Universe by using machine learning (ML). Our motivations are…”
Get full text

Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab by Amaya, M L, Jimeno, A, Kamdar, M

“…Diffuse large B-cell lymphoma (DLBCL) is the most common non Hodgkin lymphoma (NHL) in adults, and it accounts for about 30% of adult NHL cases. Newly…”
Get full text